title: Modulation of tau pathology in tau transgenic models.
abstract: NFTs (neurofibrillary tangles) in Alzheimer's disease and in tauopathies are hallmark neuropathological lesions whose relationship with neuronal dysfunction, neuronal death and with other lesions [such as Abeta (amyloid beta-peptide) pathology] are still imperfectly understood. Many transgenic mice overexpressing wild-type or mutant tau proteins have been generated to investigate the physiopathology of tauopathies. Most of the mice overexpressing wild-type tau do not develop NFTs, but can develop a severe axonopathy, whereas overexpression of mutant tau leads to NFT formation, synaptic loss and neuronal death in several models. The association between neuronal death and NFTs has, however, been challenged in some models showing a dissociation between tau aggregation and tau toxicity. Cross-breeding of mice developing NFTs with mice developing Abeta deposits increases NFT pathology, highlighting the relationship between tau and amyloid pathology. On the other hand, tau expression seems to be necessary for expression of a pathological phenotype associated with amyloid pathology. These findings suggest that there is a bilateral cross-talk between Abeta and tau pathology. These observations are discussed by the presentation of some relevant models developed recently.
authors.affiliation: Laboratory of Histology, Neuroanatomy and Neuropathology, Université Libre de Bruxelles, 808 route de Lennik, B-1070 Brussels, Belgium. jpbrion@ulb.ac.be
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Brion
authors.forename: Kunie
authors.initials: K
authors.lastname: Ando
authors.forename: Céline
authors.initials: C
authors.lastname: Heraud
authors.forename: Karelle
authors.initials: K
authors.lastname: Leroy
mesh_terms: D016229:Amyloid beta-Peptides / Q000235:genetics / Q000378:metabolism; D000818:Animals; D030801:Animals, Genetically Modified; D016923:Cell Death; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D009474:Neurons / Q000378:metabolism / Q000473:pathology / Q000502:physiology; D055503:Protein Multimerization / Q000502:physiology; D024801:Tauopathies / Q000235:genetics* / Q000473:pathology*; D016875:tau Proteins / Q000235:genetics / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D016875:tau Proteins